Introduction {#s1}
============

Essentially all eukaryotic cells contain subcellular regions that are associated with specific functions. The identity and activity of these regions are in large part defined by the proteins contained within them. Cells require an efficient sorting process to get proteins required for function to their correct location. For many genes, this fundamental problem is solved by transporting the RNA molecule encoding the protein, rather than the protein itself, to the desired location. The transcript is then translated on-site to immediately produce a correctly localized protein.

RNA localization has been studied extensively in diverse systems ([@bib20]; [@bib44]; [@bib53]). Thousands of transcripts are asymmetrically distributed within cells and therefore subject to localization regulation ([@bib8]; [@bib26]; [@bib42]; [@bib72]; [@bib74]). However, precise molecular mechanisms that govern how transcripts are transported have been worked out in detail for only a small subset of heavily studied localized RNAs ([@bib3]; [@bib20]; [@bib34]; [@bib39]). In these RNAs, sequences that mark transcripts for transport, sometimes termed 'zipcodes', are often found in 3′ UTRs ([@bib34]). Zipcode sequences are then bound by RNA-binding proteins (RBPs) that mediate RNA transport ([@bib21]; [@bib29]; [@bib69]; [@bib86]). The zipcode/RBP pairs that are known were often identified through careful but laborious reporter experiments that involve systematic deletions or mutations that inactivate putative regulatory elements.

A large disparity persists, though, between the number of RNAs that are targets of localization regulation and the number of known localization regulatory elements within those RNAs. High-throughput experiments that probe the localization of thousands of transcripts at once may be able to help bridge this gap. By providing many examples of transcripts whose localization is regulated by a given RBP, commonalities among those transcripts can shed light on general rules that define sequence features that regulate RNA localization as well as the RBP that binds them.

FMRP is an RBP that is highly expressed in the brain and has long been known to be the protein behind Fragile X syndrome (FXS) ([@bib65]). Loss of expression of the *FMR1* gene in humans is associated with intellectual disabilities and occurs in approximately 1 in 5000 males ([@bib11]). FMRP-null mice display similar phenotypes ([@bib36]). FMRP has been shown to regulate RNA metabolism at the level of translational repression and RNA localization ([@bib15]; [@bib16]). The relative contribution of these activities to observed phenotypes is generally unclear. Although genome-wide studies probing the translation repression activity of FMRP have been performed ([@bib15]), much less is known about the RNAs that depend on FMRP for efficient localization to neuronal projections. FMRP has been implicated in the transport of a handful of RNAs ([@bib16]; [@bib54]; [@bib83]), but there is no general understanding of the identity of transcripts whose localization is regulated by FMRP.

How FMRP recognizes and binds its functional targets is also not well understood. Several studies have reported transcript and RNA motif targets for FMRP in vitro and in vivo ([@bib2]; [@bib7]; [@bib12], [@bib13]; [@bib77]), yet considerable disagreement among these studies remains about the identity of RNA sequences that interact with FMRP with high-affinity ([@bib1]). RNA G-quadruplex sequences have been repeatedly identified as binding targets of FMRP ([@bib5]; [@bib12]; [@bib66]; [@bib87]), and studies that have looked at commonalities between published datasets have found enrichments for WGGA sequences consistent with G-quadruplex formation ([@bib1]; [@bib71]). However, other studies have found that FMRP binds completely different short RNA motifs ([@bib61]) while still others seem to show that FMRP displays almost no sequence specificity at all and instead binds all along the coding sequence of its target transcripts ([@bib15]). Whether or not these potentially different modes of binding are related to the different functions of FMRP is again unknown.

Results {#s2}
=======

Identification of transcripts that depend upon FMRP for efficient neuronal transport {#s2-1}
------------------------------------------------------------------------------------

We and others have previously used subcellular fractionation followed by high-throughput sequencing to quantify transcripts in the soma and neurites of neuronal cells ([@bib72]; [@bib85]). In these experiments, neuronal cells are plated on porous membranes ([Figure 1A](#fig1){ref-type="fig"}). The pores of these membranes are big enough to allow neurite growth through them but small enough to restrict soma growth to the top of the membrane. This allows the cells to be mechanically fractionated into soma and neurite fractions. RNA can then be isolated from both fractions and analyzed by high-throughput sequencing.

![Identification of FMRP localization targets.\
(**A**) Schematic of soma/neurite fractionation. Cells are plated on porous membranes. Neurites grow down through the pores, and cells are then mechanically fractionated by scraping. (**B**) Western blot of wildtype and CAD FMRP knockout cells. (**C**) Western blot of fractionated soma (S) and neurite (N) samples. Beta-actin is a marker of both soma and neurite fractions while Histone H3, being restricted to the nucleus, is a marker of soma fractions. (**D**) Localization ratio (LR) comparison for all expressed genes in wildtype and FMRP-null cells. Changes in LR values and FDR values were calculated using Xtail. (**E**) Expression changes across genotypes in the soma and neurite fractions for FMRP localization targets (red) and nontargets (gray). P-values were calculated using a Wilcoxon rank-sum test.](elife-52621-fig1){#fig1}

Given the utility of this technique, we then set out to define transcripts whose efficient localization to neurites depended on FMRP. Using CRISPR/Cas9, we created an FMRP-null CAD mouse neuronal cell line. CAD cells are derived from a mouse brain tumor and can be induced by serum starvation to display features of neuronal differentiation, including cell cycle downregulation, expression of neuronal markers, and the appearance of neuronal morphologies ([@bib59]). The CAD FMRP knockout line was found to have a single basepair deletion in all alleles of *Fmr1* ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) that caused a frameshift and a premature termination codon two codons downstream of the gRNA cut site. The premature termination codon was upstream of all identified RNA-binding domains in FMRP. The knockout cells displayed no detectable FMRP expression by immunoblotting, even when probed with a polyclonal FMRP antibody ([Figure 1B](#fig1){ref-type="fig"}).

We then fractionated wildtype and FMRP knockout CAD cells into soma and neurite fractions in triplicate. To monitor the efficiency of the fractionation, we assayed the expression of beta-actin, which should be present in all fractions, and histone H3, which, being nuclear, should be restricted to the soma ([Figure 1C](#fig1){ref-type="fig"}). RNA was isolated from each fractionation and profiled by high-throughput sequencing.

The expression of *Fmr1* RNA was downregulated in FMRP knockout samples, as would be expected since the Cas9-induced lesion likely made the RNA a target of nonsense-mediated decay ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Principal component analysis of gene expression values showed that replicates clustered together and samples were separated along the first two principal components by compartment and genotype, respectively ([Figure 1---figure supplements 3](#fig1s3){ref-type="fig"} and [4](#fig1s4){ref-type="fig"}). To quantify RNA localization, we defined a metric termed localization ratio (LR) as the log2 of a gene's abundance in the neurite fraction divided by its abundance in the soma fraction. Positive LR values are therefore associated with neurite localization, and higher LR values are associated with stronger neurite localization.

Previous literature has demonstrated that transcripts encoding ribosomal proteins and components of the electron transport chain are strongly enriched in neurites ([@bib26]; [@bib52]; [@bib72]). We therefore sought to assay the efficiency of our fractionation and RNA isolation by looking at the LR values of these genes. Reassuringly, we found that, in all samples, mRNAs encoding these proteins were strongly neurite-enriched ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}).

To further monitor the quality of our fractionations and RNA samples, we compared data produced by these fractionations to data produced by similar neuronal subcellular transcriptomic experiments that had been previously published. In total, we calculated LR values for all expressed genes from 65 samples spanning two species, four laboratories, and nine neuronal cell types ([@bib22]; [@bib51]; [@bib72]; [@bib85]; [@bib30] [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}). We found that our LR values correlated well with LR values from other studies (R \~ 0.6 to 0.8) and that all 65 samples were significantly more similar to each other than would be expected by chance ([Figure 1---figure supplement 7](#fig1s7){ref-type="fig"}), giving us confidence that our subcellular sequencing data was comparable with previously published datasets. Furthermore, we found that transcripts encoding ribosomal proteins ([Figure 1---figure supplement 8](#fig1s8){ref-type="fig"}) and components of the electron transport chain ([Figure 1---figure supplement 9](#fig1s9){ref-type="fig"}) were neurite-enriched in a large majority of samples, confirming their status as markers of neurite RNA.

To identify genes whose transcripts depend on FMRP for efficient transport to neurites, we compared the LR values of genes between the wildtype and knockout samples using the R package Xtail ([@bib81]). Xtail is designed to analyze ribosome profiling data to identify genes whose translational efficiency changes across conditions. However, since both translational efficiency and LR are ratios of gene expression values, we reasoned that Xtail would be a good tool to identify genes whose LR value changes across samples. Using Xtail and a false discovery rate cutoff of 0.01, we identified 86 genes whose transcripts displayed impaired neurite localization, and thus decreased LR values, in the FMR1 knockout ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 10](#fig1s10){ref-type="fig"}, [Supplementary file 1a](#supp1){ref-type="supplementary-material"}). We defined these genes as FMRP localization targets.

Gene ontology analysis of these targets revealed that they were enriched for genes that regulate vesicle transport in neurons ([Figure 1---figure supplement 11](#fig1s11){ref-type="fig"}). In particular, mRNAs encoding several kinesins were less localized in the FMRP knockout. Interestingly, mRNAs encoding kinesins have been recently identified as both bound and transported by FMRP in glial cells ([@bib58]).

Because LR is a ratio of neurite to soma gene expression values, in principle, a decrease in LR could be due to either a decrease in neurite expression or an increase in soma expression. To investigate this further, we compared the expression of the mislocalized genes in the soma and neurite compartments separately. We found that while the expression of FMRP localization targets did not change in the soma between the wildtype and FMRP knockout samples, their expression in the neurites of FMRP knockout cells was significantly reduced ([Figure 1E](#fig1){ref-type="fig"}). Because the soma contains the vast majority of cellular RNA, this indicates that the overall expression and processing of the localization targets is not impaired yet their ability to be trafficked to neurites is reduced. These findings suggest that these genes are in fact misregulated at the level of RNA localization.

FMRP localization targets have significant enrichments of G-quadruplex sequences in their 3′ UTRs {#s2-2}
-------------------------------------------------------------------------------------------------

After identifying functional RNA localization targets of FMRP, we then looked for commonalities among them that can give insight into how FMRP recognizes and binds them. If FMRP were directly regulating the localization of these targets, we would expect that FMRP directly binds them. To test this, we analyzed data from three previously published FMRP CLIP-seq datasets ([@bib2]; [@bib15]; [@bib48]). Given the lack of consensus between multiple published FMRP binding datasets ([@bib1]), we defined transcripts bound by FMRP as those that appeared in all three CLIP-seq datasets ([@bib2]; [@bib15]; [@bib48]). FMRP localization targets were approximately 4-fold more likely to be directly bound by FMRP than expected by chance ([Figure 2A](#fig2){ref-type="fig"}).

![Identification of transcript features associated with the regulation of localization by FMRP.\
(**A**) Fraction of FMRP localization targets (red) and nontargets (gray) that were previously identified as directly bound by FMRP in cells. FMRP-bound RNAs were defined as the intersection between three previously published datasets ([@bib2]; [@bib15]; [@bib48]). The null, expected fraction is represented by a gray dotted line. P values were calculated using a binomial test. (**B**) Change in RNA localization (knockout - wildtype) for RNAs identified as CLIP targets (red) and CLIP nontargets (gray). P values were calculated using a Wilcoxon rank-sum test. (**C**) Sixmer enrichments in the 3′ UTRs of FMRP localization targets vs nontargets. Significantly enriched 6mers (BH-adjusted p\<0.05, Fisher's exact test) are represented in red. (**D-F**) G-quadruplex sequence densities in the 3′ UTRs of FMRP localization targets (red) and nontargets (gray). P values are calculated using a Wilcoxon rank-sum test. In (**D**), G-quadruplex sequences were defined by a regular expression that contained four WGGA sequences separated by linkers of length 0--7 nt. Values represent sequence matches per nt. In (**E**), RNAfold was used to identify G-quadruplex sequences. Values represent the number of guanosine residues participating in quadruplex sequences per nt. In (**F**), experimentally defined G-quadruplex sequences were used. Values represent the number of basepairs that overlap with an experimentally defined G-quadruplex sequence per nt of UTR sequence. (**G**) Effect sizes and significance of the relationships between transcript features and whether or not a transcript's localization was regulated by FMRP. (**H**) Conservation of guanosine residues in 3′ UTRs as defined by PhyloP scores. Guanosines were separated based on whether or not they were predicted by RNAfold to participate in quadruplexes and by whether or not they were contained in FMRP localization targets. (**I**) G-quadruplex sequence density in the 3′ UTRs of the human orthologs of FMRP targets. G-quadruplexes were defined by the regular expression used in (D), and values represent quadruplex sequences per nt. (**J**) G-quadruplex sequence density in the 3′ UTRs of the human orthologs of FMRP targets. G-quadruplex sequences were defined by RNAfold as in (E), and values represent the number of guanosine residues participating in quadruplex sequences per nt.](elife-52621-fig2){#fig2}

We then performed the converse analysis to ask whether FMRP CLIP-seq targets were preferentially mislocalized in FMRP knockout cells. We found that the localization of FMRP CLIP-seq targets was significantly more sensitive to FMRP loss than CLIP-seq nontargets ([Figure 2B](#fig2){ref-type="fig"}).

To rigorously test the links between these three published CLIP-seq datasets and our FMRP localization targets, we then repeated these analyses using the FMRP CLIP-seq targets defined in each dataset individually instead of taking the overlap between them. For each CLIP-seq dataset, we found that our FMRP localization targets were enriched for FMRP binding ([Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}, [3](#fig2s3){ref-type="fig"} and [5](#fig2s5){ref-type="fig"}) and that FMRP-bound RNAs were significantly more likely to be mislocalized in FMRP knockout cells ([Figure 2---figure supplements 2](#fig2s2){ref-type="fig"}, [4](#fig2s4){ref-type="fig"} and [6](#fig2s6){ref-type="fig"}). From these analyses, we conclude that FMRP is likely directly regulating the localization of these functional RNA localization targets.

We then reasoned that sequences that were enriched in FMRP localization targets relative to nontargets could represent preferred binding sites for FMRP. Because the majority of RNA sequence elements that regulate localization identified to date reside in 3′ UTRs ([@bib34]), we compared the abundance of all 6mers in the 3′ UTRs of FMRP localization targets and nontargets. We observed a strong enrichment for the RNA sequence 'GGA' in the 3′ UTR of FMRP localization targets ([Figure 2C](#fig2){ref-type="fig"}). GGA had previously been identified from an FMRP CLIP-seq dataset as a preferred FMRP binding motif, giving us further confidence that our identified localization targets were directly bound and regulated by FMRP ([@bib2]).

Tandem repeats of GGA sequences are known to have the ability to fold into G-quadruplex sequences ([@bib71]). G-quadruplexes are four-stranded nucleic acid structures in which guanosine residues interact with each other across the strands ([@bib63]). Given that G-quadruplex structures have been shown to be specifically bound by FMRP in vitro, ([@bib17]; [@bib77]), we then asked if G-quadruplex sequences were enriched in FMRP localization target sequences. To do so, we employed two computational methods to predict G-quadruplex sequences from RNA sequences. Using a regular expression we searched for four repeated WGGA sequences separated by 0--7 nucleotide linkers ([@bib31]) where W represents either adenosine or uracil. We also used the RNA secondary structure prediction software RNAfold ([@bib45]). Both methods agreed that the 3′ UTRs of FMRP localization targets contained significantly more G-quadruplex sequences than nontargets ([Figure 2D,E](#fig2){ref-type="fig"}).

We then complemented these computational predictions of G-quadruplex sequences with previously published experimentally defined G-quadruplex sequences ([@bib27]). These were identified by quantifying reverse transcriptase stop sites in the presence of either potassium or lithium. Because potassium stabilizes G-quadruplexes and lithium destabilizes them, stop sites that display differential abundance between the two conditions are likely due to G-quadruplexes. These experimentally defined G-quadruplexes displayed many expected properties, including a large enrichment for guanosine nucleotides ([Figure 2---figure supplement 7](#fig2s7){ref-type="fig"}), highly stable predicted secondary structures ([Figure 2---figure supplement 8](#fig2s8){ref-type="fig"}), and a strong enrichment for predicted G-quadruplexes using both the regular expression and RNAfold methods ([Figure 2---figure supplements 9](#fig2s9){ref-type="fig"} and [10](#fig2s10){ref-type="fig"}). The agreement between the computational and experimental approaches to G-quadruplex identification gave us confidence in the ability of both techniques. As with the computational predictions, we observed a significant enrichment of experimentally defined G-quadruplexes in the 3′ UTRs of FMRP localization targets ([Figure 2F](#fig2){ref-type="fig"}).

We then asked what other transcript features were associated with FMRP localization targets. We observed that FMRP localization targets had much longer open reading frames and 3′ UTRs than expected ([Figure 2G](#fig2){ref-type="fig"}), consistent with previous reports that 3′ UTR extensions and alternative 3′ UTRs can regulate RNA localization in neurons ([@bib72]; [@bib76]). We observed no relationship between the overall abundance of a transcript and whether or not it was an FMRP localization target. The enrichment of G-quadruplexes in FMRP localization targets was restricted to their 3′ UTRs as we did not observe a significant relationship between CDS or 5′ UTR G-quadruplex density and localization regulation by FMRP ([Figure 2G](#fig2){ref-type="fig"}).

G-quadruplexes are not positionally conserved but tend to be present in orthologous genes {#s2-3}
-----------------------------------------------------------------------------------------

The enrichment of G-quadruplex sequences in FMRP localization targets and the enrichment of those targets in FMRP CLIP-seq datasets suggested that the G-quadruplex sequences may be functional. If they were functional, we might expect them to be conserved. To test the conservation of G-quadruplex sequences, we compared the conservation of 3′ UTR guanosine residues predicted by RNAfold to participate in quadruplex interactions to those not predicted to be in quadruplexes. Surprisingly, we found that guanosines in quadruplexes were less conserved than those not in quadruplexes, and those in FMRP localization targets were less conserved than those in nontargets ([Figure 2H](#fig2){ref-type="fig"}). However, this analysis relies on elements being positionally conserved such that they can be aligned across genomes. Elements within UTRs do not have to be positionally conserved, only present, to be functional.

To assess this, we calculated G-quadruplex densities in the 3′ UTRs of the human orthologs of the FMRP localization targets and nontargets. We observed a significant enrichment of G-quadruplexes in the human orthologs of the FMRP localization targets, arguing that their function may be conserved across species ([Figure 2I,J](#fig2){ref-type="fig"}).

Mislocalized transcripts in FXS patient-derived neurons are enriched for G-quadruplex sequences {#s2-4}
-----------------------------------------------------------------------------------------------

To more directly test the localization regulatory activity of FMRP in human cells, we created induced pluripotent stem (iPS) cell lines from FXS and unaffected patient samples. We differentiated these cells over the course of 20 days into motor neurons ([@bib9]; [@bib19]; [@bib62]; [@bib30]; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We then plated these cells on porous membranes and performed the same subcellular fractionation and sequencing experiment that was performed on the CAD cell samples using four technical replicates.

As expected, the FXS neurons displayed a large decrease in both *FMR1* RNA and FMRP protein ([Figure 3A,B](#fig3){ref-type="fig"}). We assayed the efficiency of the fractionation as before by immunoblotting ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) and looking for the enrichment of mRNAs encoding ribosomal proteins and components of the electron transport chain in the neurite fraction ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}) and found that both performed as expected. Further, LR values obtained from the iPS neurons correlated well (R \~ 0.6 to 0.8) with those obtained from previously published neuronal subcellular sequencing datasets and with the CAD cell fractionation in [Figure 1](#fig1){ref-type="fig"} ([@bib22]; [@bib51]; [@bib72]; [@bib85]; [@bib30]; [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}), indicating that the fractionation was efficient.

![RNA mislocalization in FXS neurons.\
(**A**) FMRP protein expression in motor neurons differentiated from iPS cells derived from unaffected and FXS patients. (**B**) *FMR1* transcript abundance in motor neurons differentiated from iPS cells derived from unaffected and FXS patients. (**C**) Relative LR values comparing unaffected and FXS motor neurons. Human genes were binned based on whether or not their mouse orthologs were defined as FMRP localization targets (red) or nontargets (gray) in mouse CAD cells. (**D**) Fraction of human FMRP localization targets (red) and nontargets (gray), as defined in iPS-derived motor neurons, that were previously identified as bound by FMRP in cells ([@bib2]; [@bib15]). The null, expected fraction is represented by a gray dotted line (**E-F**) G-quadruplex densities in the 3′ UTRs of human FMRP localization targets (red) and nontargets (gray) as defined using a regular expression (**E**) and RNAfold (**F**). Y-axis values depict densities as in [Figure 2C and D](#fig2){ref-type="fig"}. P values were calculated using a Wilcoxon rank-sum test.](elife-52621-fig3){#fig3}

PCA analysis of gene expression values showed a separation of samples by compartment and genotype along the first two principal components ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). We first looked at the localization of the human orthologs of the FMRP localization targets that were identified in the mouse CAD system. Strikingly, the human orthologs of the mouse FMRP localization targets were significantly less neurite-localized in FXS neurons than in unaffected neurons, indicating that the functional localization targets of FMRP were broadly conserved across species (mouse and human) and experimental systems (neuronal cell line and iPS-derived neurons) ([Figure 3C](#fig3){ref-type="fig"}). Overall, we observed a modest (R = 0.21) but highly significant (p=1e-37) correlation between the mislocalization of genes in the CAD knockout system and the mislocalization of their human orthologs in the FXS iPS system ([Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}, [Supplementary file 1b](#supp1){ref-type="supplementary-material"}).

We then defined genes whose localization differed between the FXS and unaffected samples. After quantifying the localization of genes in each sample, we found that very few genes met a reasonable FDR cutoff for mislocalization. This is perhaps due to the inherent variability in the differentiation of iPS cells into motor neurons from prep to prep or the difference in genetic background of the iPS lines adding noise to gene expression measurements ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). To define mislocalized genes, we therefore used a log2 fold change cutoff of 0.25 to define genes whose neurite-localization decreased in FXS (FMRP targets) or increased in FXS (FMRP nontargets) ([Figure 3---figure supplement 6](#fig3s6){ref-type="fig"}). We found that FMRP targets were significantly more likely to be directly bound by FMRP in cells as determined by CLIP than FMRP nontargets ([Figure 3D](#fig3){ref-type="fig"}; [@bib2]; [@bib15]; [@bib48]). We also found that FMRP targets had significantly higher densities of G-quadruplexes in their 3′ UTRs than FMRP nontargets, suggesting that this mode of localization target recognition may be conserved between mice and humans ([Figure 3E,F](#fig3){ref-type="fig"}).

The RGG domain of FMRP specifically recognizes G-quadruplex sequences {#s2-5}
---------------------------------------------------------------------

Given our findings that FMRP localization targets were enriched for G-quadruplex sequences, we next sought to determine if FMRP directly interacted with G-quadruplex RNAs over other RNAs in vitro. To this end, we performed RNA Bind-n-Seq (RBNS), a quantitative and unbiased method that defines the specificity of a given RBP or RNA binding domain by incubating purified protein with a diverse pool of 10^11^ random RNA sequences ([@bib18]; [@bib41]; [@bib73]). In this technique, the input RNA pool and protein-associated RNA are sequenced using high-throughput sequencing. RNA sequences that mediate protein binding are identified as those enriched in the protein-bound RNA relative to the input pool ([Figure 4A](#fig4){ref-type="fig"}). Importantly, this assay uses a single round of RNA selection and uncovers a continuous range of RBP specificity.

![RNA Bind-n-Seq (RBNS) of FMRP domains.\
(**A**) Schematic representation of RBNS assay and domain architecture of FMRP. (**B**) Coomassie stain of purified recombinant FMRP fragments used for RBNS experiments. (**C**) Enrichments for G-quadruplex RNA sequence motifs in the protein-associated RNA relative to input RNA in the presence of potassium (red) and lithium (blue). Bars represent means of bootstrapped subsets. Error bars represent the standard deviation across subsets. (**D**) As in C, enrichments for G-quadruplex RNA sequences as predicted by computational RNA folding in protein-associated RNA relative to input RNA. Wilcoxon rank-sum p values \< 0.01 are represented as (\*\*), and p values less than 0.001 are represented as (\*\*\*).](elife-52621-fig4){#fig4}

We set out to determine which domains within FMRP, if any, contained the ability to specifically interact with G-quadruplex sequences. FMRP contains two domain types that are known to bind RNA, a pair of KH domains and a single RGG domain ([Figure 4A](#fig4){ref-type="fig"}). We purified recombinant fragments of mouse FMRP that included either the KH domains or the RGG domain ([Figure 4B](#fig4){ref-type="fig"}). We then performed RBNS with a pool of random 40mers in the presence of either potassium, which promotes G-quadruplex folding, or lithium, which inhibits G-quadruplex folding ([@bib28]). For each condition, we sequenced approximately 10 million RNA sequences in from both the input and protein-associated RNA pools. G-quadruplex RNA sequences, defined either as matches to specific motifs or through RNA folding predictions, were approximately 10-fold enriched in the RGG-associated RNA compared to the input pool ([Figure 4C,D](#fig4){ref-type="fig"}). Furthermore, the addition of lithium drastically reduced this enrichment of G-quadruplex sequences, indicating that the G-quadruplexes must be folded in order to interact with the RGG domain in vitro, as has been previously observed ([@bib50]; [@bib60]; [@bib66]; [@bib87]).

Using fluorescence polarization assays, we found that the RGG domain interacted with a G-quadruplex RNA in the presence of potassium with a high affinity (Kd \~30 nM). This value is comparable to previous estimates of the affinity ([@bib87]). Repeating the assay in the presence of lithium showed reduced binding between the RGG domain and G-quadruplex RNA ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

The KH domains of FMRP did not specifically interact with G-quadruplex sequences ([Figure 4C,D](#fig4){ref-type="fig"}), and we were unable to uncover any strong sequence specificity in the KH-bound RNA nor derive the affinity of the KH domain for any RNA. These data suggest that FMRP binds its RNA localization targets through interactions between its RGG domain and target transcripts.

The RGG domain of FMRP as well as a G-quadruplex sequence in target mRNAs are both required for efficient localization of RNAs {#s2-6}
------------------------------------------------------------------------------------------------------------------------------

To investigate a functional relationship between the RGG domain of FMRP and G-quadruplex sequences within 3′ UTRs of localized mRNAs, we used single molecule FISH (smFISH) to monitor the localization of a reporter transcript in CAD cells that contained either no FMRP, full length FMRP, or a truncation of FMRP lacking the RGG domain. These cells were made by rescuing an FMRP knockout line with GFP, FMRP, or FMRPΔRGG, respectively ([Figure 5A](#fig5){ref-type="fig"}). The reporter transcript contained the coding sequence of Firefly luciferase followed by the 3′ UTR of the Nol3 gene (Nol3 3′ UTR). This UTR was chosen because we observed in our sequencing data that Nol3 was mislocalized in FMRP knockout CAD cells (LR log2 fold change = −0.9, p=3e-14). In separate experiments, we also monitored the localization of a version of the reporter transcript in which the only RNAfold-predicted G-quadruplex sequence had been removed (Nol3-G4 3′ UTR) ([@bib45]). The smFISH probes used to visualize the two reporters were identical and targeted the coding sequence of the transcript ([Figure 5A](#fig5){ref-type="fig"}).

![Efficient localization of a reporter transcript requires both a G-quadruplex sequence and the RGG domain of FMRP.\
(**A**) FMRP rescue constructs and smFISH reporter constructs used. smFISH probes, represented by red bars with asterisks, hybridize to the ORF of both reporter constructs. (**B**) Expression of FMRP rescue constructs in FMRP knockout-rescue CAD cells. (**C**) Representative Firefly luciferase transcript smFISH images. Images are oriented such that the cell body is toward the left. (**D**) Quantification of smFISH images. For all conditions, the number of reporter transcripts in the neurite was calculated using FISH-quant. Each dot in each condition represents a single cell. Transcript counts were normalized to those observed in the full length FMRP, Nol3 UTR condition. P values were calculated using a Wilcoxon rank-sum test. (**E**) Quantification of FMRP/Firefly luciferase RNA interaction using CLIP-qPCR. Wilcoxon rank-sum P values of less than 0.001 are represented by three asterisks. (**F**) Quantification of FMRP trafficking using immunofluorescence. For each cell, the proportion of fluorescence present in the neurite was quantified and normalized to total fluorescence in the entire cell. P values were calculated using a Wilcoxon rank-sum test.](elife-52621-fig5){#fig5}

Both the *FMR1* rescue constructs and the reporter transcripts were integrated into the genome of the CAD cells using Cre-lox recombination into a single genomic site ([@bib37]). Using this strategy, cell pools were virtually homogeneous for integration of the rescue constructs, and the expression of both the rescue constructs and the reporter transcripts were controllable with doxycyline. Protein levels were assayed via western blot with or without doxycycline induction to confirm expression of rescue constructs. We found that the expression level of FMRP in the rescued cells was similar to the expression of FMRP in wildtype cells ([Figure 5B](#fig5){ref-type="fig"}). We then monitored the efficiency of reporter transcript localization to neurites by smFISH and quantified the results using FISH-quant ([@bib55]). We observed that the reporter transcript that contained a G-quadruplex sequence in its 3′ UTR was efficiently localized to neurites, but only in cells expressing full length FMRP (FMRP, Nol3 3′ UTR), and not in cells either completely lacking FMRP (GFP, Nol3 3′ UTR) or in cells expressing only a truncated form of FMRP (ΔRGG, Nol3 3′ UTR) ([Figure 5C,D](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Removal of the G-quadruplex sequence (Nol3-G4 3′ UTR) resulted in less efficient transcript localization regardless of the FMRP status of the cell ([Figure 5C,D](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These results are consistent with both the RGG domain of FMRP and a G-quadruplex sequence within the target transcript being required for efficient localization to neurites.

This observed defect in the transport of G-quadruplex-containing transcripts in the absence of the RGG domain of FMRP could be explained by two potential possibilities. It could be that the ΔRGG truncation was unable to bind the transcript in cells, or, alternatively, it could be that the ΔRGG truncation was unable to be transported to neurites. To distinguish between these possibilities, we tested the abilities of the ΔRGG truncation and the full length protein to bind the reporter transcripts in cells using CLIP-qPCR ([@bib82]) and assayed their ability to be transported to neurites using immunofluorescence.

To assay RNA binding ability, cells coexpressed one of the Firefly luciferase reporters, either containing or lacking a G-quadruplex ([Figure 5A](#fig5){ref-type="fig"}), and Renilla luciferase from a bidirectional promoter. RBPs were crosslinked to their bound RNAs using UV irradiation, and the rescuing FMRP construct was immunoprecipitated. By comparing the amounts of Firefly and Renilla luciferase transcripts in the input and immunoprecipitated samples using qPCR, relative levels of FMRP/Firefly RNA interaction in cells were determined. We found that the ΔRGG truncation showed significantly reduced interaction with the G-quadruplex-containing Firefly reporter compared to full length FMRP ([Figure 5E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). When we repeated the experiment using the Firefly reporter lacking the G-quadruplex, both full length FMRP and the ΔRGG truncation showed reduced, but importantly, equal, ability to bind the transcript ([Figure 5E](#fig5){ref-type="fig"}). These results are consistent with the in vitro results of the RBNS assay shown in [Figure 4](#fig4){ref-type="fig"}.

To address the ability of the ΔRGG truncation to be transported to neurites, we assayed the subcellular location of full length FMRP and the ΔRGG truncation using immunofluorescence. We found that cells expressing full length FMRP and the ΔRGG truncation displayed approximately equal proportions of the total cellular FMRP in their neurites, indicating that the full length protein and the truncation are trafficked to neurites at approximately similar levels ([Figure 5F](#fig5){ref-type="fig"}). Based on these results, we conclude that the observed defect in the localization of G-quadruplex-containing transcripts in cells expressing the ΔRGG truncation is likely due to a reduced ability of FMRP to bind the transcript and not a reduced ability of the protein to be trafficked.

To probe the functional relationship between the RGG domain of FMRP and G-quadruplex sequences transcriptome-wide, we fractionated the FMRP rescue lines into soma and neurite fractions and analyzed RNA from those fractions using high-throughput sequencing. We observed enrichments for mRNAs encoding ribosomal proteins and electron transport chain components in the neurites of all samples, indicating that fractionation of the cells was successful ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Transcriptome-wide measures of RNA localization, as measured by LR values of all genes in the GFP and ΔRGG lines were strongly correlated. This is consistent with neither of these lines containing a localization-competent form of FMRP. Full length FMRP rescue samples were outliers in this analysis compared to the GFP and ΔRGG samples, perhaps due to the active localization regulatory activity of full length FMRP ([Figure 6A](#fig6){ref-type="fig"}, [Supplementary files 1c, 1d, 1e](#supp1){ref-type="supplementary-material"}).

![The RGG domain of FMRP is required for the localization of G-quadruplex-containing transcripts transcriptome-wide.\
(**A**) Correlation of LR values for all expressed genes in FMRP rescue samples. (**B**) G-quadruplex density, as measured by RNAfold, in the 3′ UTRs of transcripts that were more localized in the GFP rescue cells (dark gray, left) or full-length FMRP rescue cells (red, right). P values were calculated using Wilcoxon rank-sum tests. As in [Figure 2D](#fig2){ref-type="fig"}, values represent the number of guanosine residues participating in quadruplex sequences per nt. (**C**) As in (B), but comparing transcripts that were more localized in the FMRP RGG truncation rescue (dark gray, left) or the full length FMRP rescue (red, right).](elife-52621-fig6){#fig6}

We then compared changes in localization across samples by looking at changes in LR values for all genes. We found that comparing LR values in the full length FMRP rescue to either the GFP rescue or ΔRGG rescue produced highly concordant results ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}), consistent with both comparisons involving one functionally active FMRP condition and one functionally inactive FMRP condition. These comparisons were also strongly positively correlated with our original CAD knockout experiment in which FMRP null and wildtype cells were compared ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

Next, we compared the 3′ UTR G-quadruplex densities of genes that were differentially localized between given rescue conditions. When we compared the GFP rescue samples and full length FMRP rescue samples, we found that genes that were significantly more localized in the FMRP rescue cells contained significantly more G-quadruplex sequences in their 3′ UTRs than expected, consistent with our previous results ([Figures 6B](#fig6){ref-type="fig"} and [2D--F](#fig2){ref-type="fig"}). When we performed the same analysis comparing the FMRPΔRGG rescue samples to the full length FMRP rescue samples, we again found that genes whose localization was significantly more efficient in the full length FMRP samples contained significantly more 3′ UTR G-quadruplex sequences than expected ([Figure 6C](#fig6){ref-type="fig"}). This suggests that, transcriptome-wide, the RGG domain of FMRP is important for the neurite-localization of RNA molecules that contain G-quadruplex sequences. Consistent with this, we observed no relationship between the G-quadruplex content of an RNA and its differential localization in the GFP rescue and FMRPΔRGG rescue samples ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}).

The translational regulatory targets and RNA localization targets of FMRP are distinct pools of transcripts {#s2-7}
-----------------------------------------------------------------------------------------------------------

FMRP is known to regulate mRNA metabolism at the level of RNA localization and translation ([@bib15]; [@bib16]). We wondered whether the transcripts targeted by these activities were largely the same or distinct. To address this question, we identified FMRP translational regulatory targets by performing ribosomal profiling on wildtype and FMRP null CAD cells ([@bib32]). We observed that our ribosome protected fragments displayed strong enrichments for coding regions as well as a strong three nucleotide periodicity, indicating that the ribosome profiling data was of high quality ([Figure 7---figure supplements 1](#fig7s1){ref-type="fig"}--[4](#fig7s4){ref-type="fig"}).

We used the software package Xtail to identify transcripts that displayed significantly different ribosome occupancies in wildtype and FMRP null CAD cells ([Figure 7---figure supplement 5](#fig7s5){ref-type="fig"}, [Supplementary File 1f](#supp1){ref-type="supplementary-material"}; [@bib81]). Previous studies had reported that FMRP predominantly negatively regulates translation by inducing ribosome stalls ([@bib15]). Since stalls may result in ribosome pileups and increased ribosome densities, we reasoned that FMRP translation targets should have a lower ribosome occupancy in FMRP null cells, even though their rate of translation and protein output is increased in the absence of FMRP ([Figure 7A](#fig7){ref-type="fig"}). This is an important consideration, especially when investigating a protein that is believed to induce ribosome stalling. Cycloheximide-based ribosome profiling data informs on the locations of all ribosomes, not just translating ribosomes, and this is why we prefer the term 'ribosome occupancy' to 'translational efficiency' when referring to this data. We found genes that displayed reduced ribosome occupancy in FMRP null cells compared to wildtype cells were significantly more likely to have been identified as FMRP CLIP targets than expected ([Figure 7B](#fig7){ref-type="fig"}; [@bib2]; [@bib15]; [@bib48]), consistent with FMRP either generally acting to inhibit translation by inducing ribosome stalling or with FMRP generally acting as a translational activator ([@bib25]).

![The translational regulation targets of FMRP are distinct from its RNA localization targets and have no relationship to G-quadruplex sequence density.\
(**A**) Schematic of how the removal of FMRP, which is known to cause ribosome stalls, may affect overall ribosome density on a transcript. (**B**) Fraction of genes whose ribosome occupancy significantly decreased (blue) or increased (orange) in the FMRP null samples that were previously identified as bound by FMRP in cells. The null expectation is represented by a gray dotted line. P values were calculated using a binomial test. (**C**) Overlap of FMRP localization targets (red) and translational repression targets (blue). P values were calculated using a Binomial test. (**D**) G-quadruplex density, as determined by RNAfold, for the 3′ UTRs of transcripts whose ribosome occupancy was decreased (blue) or increased (orange) in the FMRP-null samples. P values were calculated using a Wilcoxon rank-sum test. (**E**) G-quadruplex density, as measured by RNAfold, in the 3′ UTRs of transcripts that were more localized in GFP rescue cells (dark gray, left) or FMRP I304N rescue cells (red, right). P values were calculated using Wilcoxon rank-sum tests. (**F**) Model for how FMRP recognizes its targets. RNA localization targets are recognized through the interaction of the RGG domain and a G-quadruplex sequence in the 3′ UTR of the transcript. Translational regulation targets are recognized through the interaction of one or both KH domains with an unknown transcript feature, or perhaps through interaction with ribosomes.](elife-52621-fig7){#fig7}

We found a significant but weak correlation between the mislocalization (as measured by changes in LR) and translational repression (as measured by changes in ribosome occupancy) of transcripts due to FMRP (R = 0.08, p=4.1e-16). However, when we looked at the transcripts that were statistically significantly affected in the two conditions, we found no significant overlap between the translational regulatory targets and the RNA localization targets of FMRP, suggesting that the protein exerts these activities on largely distinct pools of transcripts ([Figure 7C](#fig7){ref-type="fig"}). While the localization targets of FMRP were enriched for genes that regulate transport in cells ([Figure 1---figure supplement 7](#fig1s7){ref-type="fig"}), the translational regulatory targets were enriched for genes that regulate RNA metabolism and for those that regulate synaptic activity ([Figure 7---figure supplement 6](#fig7s6){ref-type="fig"}).

We also found no relationship between the 3′ UTR G-quadruplex content of a transcript and whether or not it was translationally regulated by FMRP ([Figure 7D](#fig7){ref-type="fig"}). Identifying transcript features associated with translational regulation by FMRP proved difficult as the transcript features most strongly associated with FMRP translation targets were the GC content and length of the transcript's CDS ([Figure 7---figure supplements 7](#fig7s7){ref-type="fig"} and [8](#fig7s8){ref-type="fig"}). Translational regulatory targets of FMRP were strongly enriched for having GC-poor, long CDS sequences. These effects are difficult to disentangle, however, as transcript GC content and length are correlated with each other in multiple species ([@bib47]) as well as with a variety of other metrics, including conservation, expression, and RNA secondary structure.

Given that the target pools of the translation and RNA localization activities of FMRP appear to be distinct, we wondered whether these two activities could be functionally separated. To address this, we assayed the ability of a point mutant of FMRP, I304N, to promote localization of G-quadruplex-containing transcripts. The I304N mutation is in one of the KH domains of FMRP and renders the protein unable to interact with polysomes ([@bib23]) and unable to repress translation ([@bib40]). As with the ΔRGG truncation, we created CAD cells that express the I304N mutant by rescuing FMRP-null cells through site-specific integration of an I304N cDNA using Cre-lox recombination ([@bib37]). We fractionated these cells into soma and neurite fractions, and then sequenced RNA collected from both fractions. Quality control metrics for the fractionation indicated that it was of high quality ([Figure 1---figure supplements 6](#fig1s6){ref-type="fig"}, [8](#fig1s8){ref-type="fig"} and [9](#fig1s9){ref-type="fig"}). We then compared RNA localization, transcriptome-wide, between FMRP-null cells rescued with GFP and cells rescued with I304N.

We found that transcripts that were more efficiently localized in the I304N sample contained significantly more G-quadruplexes than expected, indicating that the I304N mutant retains the ability to promote the localization of G-quadruplex-containing transcripts ([Figure 7E](#fig7){ref-type="fig"}, [Supplementary file 1g](#supp1){ref-type="supplementary-material"}). In support of this result, we found that wildtype FMRP and the I304N mutant were transported to neurites with approximately equal efficiencies, as had been previously reported ([Figure 7---figure supplement 9](#fig7s9){ref-type="fig"}; [@bib67]; [@bib78]).

When we compared localization data from cells expressing full length, wildtype FMRP to those expressing the I304N mutant, we found that the mutant was deficient in promoting the localization of G-quadruplex-containing messages compared to the wildtype ([Figure 7---figure supplement 10](#fig7s10){ref-type="fig"}, [Supplementary file 1h](#supp1){ref-type="supplementary-material"}). However, the I304N mutant is approximately four fold more lowly expressed than the wildtype in these cells ([Figure 7---figure supplement 11](#fig7s11){ref-type="fig"}). This decreased expression of the I304N mutant is consistent with previous reports of reduced I304N expression in I304N mouse mutants ([@bib84]). Given that in our system the wildtype and I304N mutant proteins are integrated and expressed from the same locus using the same promoter, we propose that this decrease in I304N protein expression is due to decreased protein stability.

From these results, we conclude that an FMRP mutant that is unable to regulate translation is still able to regulate the localization of G-quadruplex-containing transcripts. We propose a model in which the recognition of a G-quadruplex sequence within the 3′ UTR of a transcript by the RGG domain of FMRP is associated with localization of the transcript. Conversely, the recognition of some as-yet unidentified transcript feature by one or both of the KH domains of FMRP may be associated with translational regulation ([Figure 7F](#fig7){ref-type="fig"}). This transcript feature, if it exists, has been difficult to identify as both bioinformatic sequence analysis of the translational regulation targets of FMRP and the RNA sequences specifically bound by the KH domains of FMRP in the RBNS experiment yielded no strongly enriched motifs.

This model is supported by three observations. First, although some studies have found that the RGG domain of FMRP is required for efficient interaction of the protein with polyribosomes ([@bib4]), other studies have found that the RGG domain of FMRP is at least partially dispensable for this interaction while the KH domains are absolutely required ([@bib10]; [@bib14]; [@bib49]). Second, the I304N mutation, which is in one of the KH domains, abolishes polyribosome association ([@bib23]) and translation repression activity ([@bib40]), but not localization activity. Third, G-quadruplex sequences are unable to compete with polysomes for binding to FMRP ([@bib13]). Taken together, these findings support the idea that the dual functionalities of FMRP are driven by distinct binding capabilities of its different RNA binding domains.

Discussion {#s3}
==========

Hundreds to thousands of transcripts are asymmetrically distributed within cells, yet the mechanisms that regulate trafficking are known for only a handful ([@bib8]; [@bib26]; [@bib42]; [@bib74]; [@bib79]). In this study we have used genome engineering, subcellular fractionation, and high-throughput sequencing to identify transcripts that depend on FMRP for transport in neuronal cells. These FMRP localization targets displayed a large enrichment for G-quadruplex sequences, particular in their 3′ UTRs, suggesting that FMRP specifically recognizes these sequences to target them for transport. G-quadruplex sequences were not enriched in the translational regulatory targets of FMRP as identified by ribosome profiling. In fact, no recognizable sequence motif was strongly enriched in the translational regulatory targets beyond a negative correlation with GC content. These apparent dual modes of target recognition and the lack of clear specificity in the translational regulatory targets may explain some of the previously reported conflicting results in regards to the preferred RNA binding sites of FMRP ([@bib1]).

Our results raise the question as to how an RNA that is targeted to neurites through the action of FMRP is not subject to translational regulation by FMRP. Although we did not test these hypotheses here, we propose these potential mechanisms. We found that binding events that lead to RNA transport frequently occur in the 3′ UTR, while other studies have found that binding events associated with translation regulation occur in the open reading frame ([@bib15]). Perhaps where FMRP contacts the RNA plays a role in the regulatory effects it can exert. Alternatively, the two activities of the protein could be differentially regulated spatially or in response to stimulus.

FMRP has long been known to bind to G-quadruplex sequences ([@bib1]; [@bib12]; [@bib71]), and G-quadruplex sequences have been shown to be sufficient for transport to neurites ([@bib70]). In this work, we formally and directly combine those facts to functionally relate the ability of FMRP to bind G-quadruplexes with its ability to transport RNA molecules. It is important to note that we cannot formally prove that the G-quadruplex sequences enriched in FMRP localization targets are actually folded in cells. Recent reports have demonstrated that the majority of RNA sequences that have the ability to fold into G-quadruplex structures in vitro may be generally unfolded in cells ([@bib27]). Still, previous reports and our data demonstrate that the G-quadruplexes must be folded in order to be efficiently bound by FMRP ([@bib70]), and G-quadruplex sequences have been reported to be under purifying selection ([@bib43]).

No clear links have yet been found between the mislocalization of a specific transcript or transcripts in FXS neurons and FXS phenotypes. The relative contribution of the RNA localization and translational regulation activities of FMRP to FXS phenotypes similarly remain unclear. However, the fact that the I304N mutant, which is unable to inhibit translation but still able to regulate RNA localization, is associated with FXS phenotypes clearly points to the translational regulatory activity of FMRP being important. Further work is needed to more fully understand mechanistic links between RNA localization and neurological diseases including FXS.

For the vast majority of localized transcripts, in neurons and elsewhere, the RBP/RNA interactions that mediate transport are completely unknown. Classically, experiments designed to address these questions have focused on one transcript at a time and take the approach of systematic deletions and/or mutations to identify minimal sequence elements that regulate localization ([@bib24]; [@bib35]; [@bib38]; [@bib39]). While these experiments have been successful and provided key insights for the field, they are quite labor-intensive, and it is difficult to derive general rules that govern RNA localization from isolated, single-transcript examples. RBP-perturbation experiments followed by transcriptomic profiling have been highly successful in elucidating mechanisms that underlie other RNA metabolic processes, including pre-mRNA processing, translation, and decay ([@bib33]; [@bib56]; [@bib79]). By extending these techniques to the study of RNA localization, we envision this study as providing a framework for the investigation of other RBPs and their effects on RNA trafficking. Given that RNA mislocalization has been associated with a range of neurological diseases ([@bib80]), these studies can lay groundwork that links molecular defects to observed phenotypes.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                            Designation                                Source or reference   Identifiers                                                                            Additional information
  (species) or resource                                                                                                                                                                            
  ---------------------------------------- ------------------------------------------ --------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------
  Gene (*Mus musculus*)                    Fmr1                                                             ENSMUSG00000000838                                                                     

  Sequence-based reagent                   Fmr1 guide RNA                                                                                                                                          Used to create mouse FMR1-null cells, cloned into pX330\
                                                                                                                                                                                                   AAATTATCAGCTGGTAATTT

  Cell line (*Mus musculus*)               CAD                                        Sigma                 08100805-1VL, RRID:[CVCL_0199](https://scicrunch.org/resolver/CVCL_0199)               

  Cell line (*Mus musculus*)               CAD/loxP                                   [@bib37]                                                                                                     Contains single integration of loxP cassette

  Transfected construct (*Mus musculus*)   Fmr1 cDNA                                  Dharmacon             BC079671.1                                                                             

  Antibody                                 Mouse anti FMR1, monoclonal                Proteintech           66548                                                                                  1:5000 dilution for immunoblotting

  Antibody                                 Mouse anti HA, monoclonal                  Genscript             GenScript Cat\# A01244, RRID:[AB_1289306](https://scicrunch.org/resolver/AB_1289306)   1:2000 for immunofluorescence

  Sequence-based reagent                   smFISH probes against Firefly luciferase   BioSearch             VSMF-1006--5                                                                           

  Commercial assay or kit                  Zymo Quick-RNA Microprep kit               Zymo Research         R1050                                                                                  

  Other                                    Cell culture inserts for fractionatoin     Corning               353102                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Construction of an FMRP-null CAD line {#s4-1}
-------------------------------------

CAD cell lines were authenticated using STR profiling and were found to be mycoplasma negative. The guide RNA sequence AAATTATCAGCTGGTAATTT was cloned into pX330 (gift of F. Zhang) using the BbsI sites. This plasmid was then transfected into CAD cells using Lipofectamine LTX. Forty-eight hours after transfection, the cells were sorted to single cells using a flow cytometer and allowed to grow without interference for two weeks. Clones were screened for FMRP expression using a polyclonal FMRP antibody (MBL International RN016P). Lesions at the locus of cutting were identified by PCR using genomic DNA to amplify the locus followed by Topo cloning of the PCR fragment and Sanger sequencing of individual bacterial colonies.

Sequencing of subcellular transcriptomes from wildtype and FMRP null CAD cells {#s4-2}
------------------------------------------------------------------------------

CAD cells were grown in DMEM/F12 (Gibco 11320033) supplemented with 10% FBS at 37C in 5% CO~2~. To fractionate CAD cells into soma and neurite fractions, CAD cells were plated on porous, transwell membranes that had a pore size of 1.0 micron (Corning 353102). One million CAD cells were plated on each membrane. These membranes fit in one well of a six well plate, and six membranes were combined to comprise one single preparation. After allowing the cells to attach, the cells were induced to differentiate into a more neuronal state through the withdrawal of serum. Cells were then differentiated on the membranes for 48 hr.

To fractionate the cells, the membranes were washed one time with PBS. One mL of PBS was added to the top (soma) side of the membrane. The top side of the membrane was then scraped repeatedly and thoroughly with a cell scraper and the soma were removed into an ice-cold 15 mL falcon tube. After scraping, the membranes were removed from their plastic housing with a razor blade and soaked in 500 µL RNA lysis buffer (Zymo R1050) at room temperature for 15 min to make a neurite lysate. During this time, the 6 mL of soma suspension in PBS was spun down and resuspended in 600 µL PBS. 100 µL of this soma sample was then carried forward for RNA isolation using the Zymo QuickRNA MicroPrep kit (Zymo R1050). In parallel, RNA was also isolated from the 500 µL neurite lysate using the same kit. Typically, the neurite RNA yield from the six combined membranes was 500--1000 ng. The efficiency of the fractionation was assayed by Western blotting using anti-beta-actin (Sigma A5441, 1:5000) and anti-Histone H3 (Abcam ab10799, 1:10000) antibodies.

PolyA-selected, stranded libraries were constructed using 25 ng total RNA and an Illumina Neoprep library preparation system. The resulting libraries were then sequenced on an Illumina NextSeq 500 sequencer using paired-end, 75 bp reads. Approximately 40 million read pairs were obtained per sample. Each condition (wildtype and FMRP null; soma and neurite) was prepared and sequenced in triplicate for a total of 12 samples.

Quantification of RNA localization from CAD subcellular sequencing data {#s4-3}
-----------------------------------------------------------------------

Transcript abundances were calculated from read files using kallisto (CAD Fmr1 knockout) ([@bib6]) or using salmon v0.11.1 (CAD Fmr1 rescue samples, FXS iPS samples) ([@bib57]) with the options \--`seqBias` and \--`gcBias`. Transcript abundances were then collapsed to gene abundances using txImport ([@bib68]). LR values for genes were calculated as log2 of the ratio of neurite/soma normalized counts for a gene produced by DESeq2 using the salmon/tximport calculated counts ([@bib46]). Genes with less than 10 counts in any sample were excluded from further analyses. To identify genes whose LR values significantly changed across conditions, the Xtail software package was used ([@bib81]). Xtail is designed to process ribosome profiling data and identify genes whose ribosome occupancy changes across conditions. However, since ribosome occupancy is simply a ratio of expression count values (ribosome footprints/RNAseq), we reasoned that since LR is also a ratio of expression count values (neurite/soma), Xtail could be used to identify genes whose LR value changed across conditions. For further analyses of this data, mislocalized genes were defined as those with a FDR of less than 0.01.

Identification of transcript features associated with mislocalized genes {#s4-4}
------------------------------------------------------------------------

To ask if previously identified FMRP-interacting transcripts were enriched in our set of mislocalized genes, we defined FMRP-interacting transcripts as the intersection of RNA targets identified in two earlier studies ([@bib2]; [@bib15]) as was previously done ([@bib71]).

To identify 6mer sequences enriched in the 3′ UTRs of mislocalized genes, we calculated the abundance of all 6mers in the UTRs of mislocalized genes and, as a control, in the UTRs of expressed but non-mislocalized genes. These abundances were then compared using a Fishers exact test, and the resulting p values were corrected for multiple hypothesis testing using the Benjamini-Hochsberg method.

To computationally identify predicted G-quadruplex sequences, we used two approaches. First, to identify WGGA sequences separated by variable length linkers, we searched sequences using the regular expression (?=(\[AU\]GGA(.{0,6})\[AU\]GGA(.{0,6})\[AU\]GGA(.{0,6})\[AU\]GGA)). Alternatively, we analyzed sequences using a sliding window approach and RNAfold ([@bib45]). The window was 80 nt wide and slid 20 nt at a time. The sequence within each window was analyzed using RNAfold and the -g option. Nucleotides with a '+' for their predicted structure status were designated as nucleotides participating in a quadruplex.

For analyses involving experimentally defined G-quadruplex sequences, data was taken from previously published experiments using RNA purified from mouse embryonic stem cells that utilized RT stops that occurred with differential frequency in G-quadruplex promoting (potassium) conditions and G-quadruplex inhibiting (lithium) conditions ([@bib27]). The data taken from this paper contained RT stop sites, the 60 nt upstream of the stop site, and the frequency at which those sites were observed in the potassium and lithium conditions. RT stops representing G-quadruplexes were defined as those which were observed at least five times more frequently in the potassium data than in the lithium data. For those sites, the G-quadruplex region was defined as the 60 nt immediately upstream of the stop.

Cliff's delta values representing the effect sizes associated with each transcript feature and its association with FMRP-mediated localization were calculating using the orddom package in R ([@bib64]).

G-quadruplex conservation analyses {#s4-5}
----------------------------------

To ask if G-quadruplexes were positionally conserved, PhyloP scores were calculated for all G nucleotides in all 3′ UTRs. If the G nucleotides were predicted by RNAfold to be participating in quadruplexes as discussed above, their scores were put in one bin. If they were not predicted to be participating in quadruplexes, they were put in another bin. The scores of the G nucleotides in the two bins were then compared.

FXS iPSC line generation and iPSC culture iPSCs were generated by transducing control and FXS patient fibroblasts with Sendai virus from the Cytotune 2.0 Reprogramming Kit (Life Technologies) per the manufacturer's protocol. Briefly, early passage fibroblasts were cultured in fibroblast medium (10% ES-qualified FBS, 0.1 mM NEAA, 55 µM β-mercaptoethanol, high glucose DMEM with Glutamax) for two days. On day 0, fibroblasts were transduced with Sendai virus encoding KOS, hc-Myc, hKlf4, each at an MOI of 5. Cells were fed with fibroblast medium every other day for one week. On day 7, cells were passaged onto vitronectin (Life Technologies) coated dishes at a density of 250,000 to 500,000 cells/well. Beginning on day 8, cells were fed every day in Essential eight medium (Life Technologies) and colonies began to emerge within another 7--10 days. Individual iPSC colonies were manually picked and transferred to a dish coated with either vitronectin or Matrigel (BD) and expanded as clonal lines. All iPSC lines were karyotyped (WiCell) and characterized for expression of markers of pluripotency using immunofluorescence and RT-PCR. Additionally, we confirmed loss-of-function of *FMR1* in our FXS patient iPSC lines by taqman assays for *FMR1* mRNA and western blotting for FMRP. iPSCs were maintained on Matrigel coated dishes and fed every day with complete mTesR1 medium (Stem Cell Technologies). iPSCs were passaged every 5--7 days using ReLeSR (Stem Cell Technologies).

FXS iPS line differentiation into motor neurons {#s4-6}
-----------------------------------------------

Motor neurons were generated using an improved, suspension culture-based protocol based on previously published Dual-Smad inhibition approaches ([@bib9]; [@bib19]; [@bib62]). iPSCs were grown as clusters in suspension, and differentiated in a set-wise fashion as outlined in Supp. [Figure 3a](#fig3){ref-type="fig"}. Briefly, clusters were exposed to Smad and ROCK inhibition and WNT activation during the first 6 days, followed by activation of the retinoic and sonic hedgehog pathways. At day 10 the clusters were dissociated, and single cells were plated on membranes coated with Matrigel (Corning) in maturation media until d18-21 when MNs were analyzed.

Fractionation of iPS neurons into soma and neurite fractions {#s4-7}
------------------------------------------------------------

Generally, iPS neurons were fractionated in a very similar method as the CAD cells. However, since the iPS neurons usually contained less material, instead of combining six wells together into one prep as was done for the CAD cells, between 6 and 12 wells were combined together. After mechanical fractionation by scraping into soma and neurite fractions and RNA isolation using the Zymo Quick RNA Microprep Kit, between 100 and 500 ng of neurite RNA was obtained.

Fractionation efficiency was monitored by protein dot blot using the beta-actin and histone H3 antibodies described above. PolyA-selected, stranded RNAseq libraries were constructed using the Kapa mRNA Hyperprep kit, 100 ng of total RNA, and 15 PCR cycles of library amplification. Each condition (FXS and unaffected; soma and neurite) was fractionated, prepared, and sequenced with four replicates for a total of 16 samples. Samples were sequenced using paired-end, 150 nt sequencing on an Illumina NovaSeq. Approximately 30 million read pairs were obtained per sample.

Analysis of iPS neuron subcellular transcriptome data {#s4-8}
-----------------------------------------------------

Raw sequencing data from the iPS soma and neurite samples were analyzed using salmon and tximport as described above. After analysis of changes in RNA localization between FXS and unaffected samples using Xtail, very few genes met a reasonable FDR threshold for being significantly different between conditions. This may be a reflection of the increased variance in expression values in these samples relative to the CAD samples, perhaps due to slight variations between preps in the differentiation from iPS cells into motor neurons. For the analysis of G-quadruplex densities in mislocalized genes, mislocalized genes were identified as those who had a log2 fold change in LR across conditions (FXS vs unaffected) of at least 0.25.

RNA Bind-n-Seq protein purification and sequence analysis {#s4-9}
---------------------------------------------------------

Rosetta*E. coli*cells were transformed with pGEX6 bacterial expression constructs (GE Healthcare) harboring GST-SBP (streptavidin binding peptide)-RGG or the two KH domains from mouse FMRP. The RGG domain was defined as residues 478--614 and the KH domains were defined as residues 222--315 from mouse FMRP1. Cultures were grown in LB broth until the optical density reached \~0.8. Cultures were brought to 16°C and induced with IPTG overnight. Cells were then harvested and lysed in lysis buffer (25 mM Tris-HCl, 150 mM NaCl, 3 mM MgCl2, 1% Triton X-100, 500units/per 1L culture Benzonase Nuclease, 20 mg/L Lysozyme, Pierce Protease Inhibitor tablets). Cell pellets were then sonicated, incubated for 30 min on ice, and centrifuged at 12500 rpm for 40 min. Supernatants were passed through a 0.45 micron filter and GST-tagged proteins were purified using GST-trap FF columns (GE). Samples were further subjected to size exclusion chromatography (Superdex 200 Increase 10/300 GL column (GE)). Pure fractions were pooled together and concentrated by centrifugation (Amicon Ultra-0.5mL Centrifugal Filter Units). Purity was assessed by PAGE and Coomassie stain.

The RNA Bind-n-Seq assay was performed similar to previously described ([@bib18]). Briefly, RNA with a random region of 40nt was prepared by in vitro transcription. The RNA pool resolved by PAGE and purified. Concentrated RNA was heated at 85C for 5 min in the presence of 150 mM KCl or LiCl and allowed to cool for at least 3 min to allow for folding. Binding reactions were performed as previously described ([@bib18]). All wash and binding buffers contained either 150 mM KCl or LiCl. Protein-RNA complexes were eluted, RNA isolated and prepared for sequencing as previously described ([@bib18]).

Sequence enrichments in RNA Bind-n-Seq data were obtained in three ways. First, kmer frequencies (k = 3--6) were computed in protein-bound libraries and compared to kmers in the input library. For each kmer, the ratio of its frequency in the protein-bound library to the input library results in an enrichment or 'R' value for every kmer, as was previously reported ([@bib18]). To identify G quadruplex sequences, we determined the fraction of protein-bound reads with matches to a variety of G quadruplex motifs (e.g. GGGN1-7GGGN1-7 GGGN1-7GGG) and compared that to the number of input reads with the same motif. Lastly, we used RNAfold version 2.4.11 ([@bib45]) to predict G quadruplexes (RNAfold -g option) in the 40 nucleotide randomized regions of input and bound RNAs. As with the pattern match approach, the ratio of protein-bound to input reads predicted to fold into G quadruplexes was computed. In each case reads were subsampled for estimates. Error bars shown in figures represent standard deviation from mean across subsamples.

Fluorescence polarization assay {#s4-10}
-------------------------------

RNAs labeled at the 3′ end with 6-FAM were purchased from Integrated DNA Technologies. The RNA sequences used were: 5'-GGGAGGGAGGGAGGGUA-6FAM-3' (rG4) and 5'-CCCCCCUCCCCCCU-6FAM-3' (CTRL RNA). rG4 was heated to 100°C in the presence of 150 mM KCl (promoting G-quadruplex formation) or 150 mM LiCl (disrupting G-quadruplex formation) for 3 min and allowed to cool down to room temperature for at least 15 min. rG4 was then mixed with binding buffer containing 150 mM KCl (or LiCl), 10 mM Tris-HCl and 5% glycerol. Cation usage (K+ or Li+) was kept constant throughout the assay. The RGG domain of FMRP was purified and then serially diluted with binding buffer to concentrations between 1 µM to 2 nM. The RGG domain was then incubated with 10 nM of rG4 in potassium, rG4 in lithium or CTRL RNA. After incubation for 5 min at 25°C, plates were centrifuged at 1000 rpm for 1 min. Fluorescence polarization was monitored with a PHERAstar plate reader (BMG Labtech) at 26--27°C.

Construction of an FMRP-null CAD line with single LoxP cassette {#s4-11}
---------------------------------------------------------------

CAD LoxP cell lines were received from the lab of Eugene Makeyev ([@bib37]). This line contains a single loxP cassette in the genome of the cells to facilitate recombination of exogenous constructs. A knockout insertion cassette was introduced to exon 6 of the endogenous *Fmr1* gene via CRISPR-Cas9 technology to generate CAD LoxP FMRP KO cells. This cassette includes stop codons in all frames as well as a strong polyadenylation signal. 300 nt of homology on either side of the gRNA cut site was included to facilitate homology directed repair. A G418 resistance gene was included to select for integration. pX330 was used to express Cas9 and the guide RNA sequence AAATTATCAGCTGGTAATTT. Following selection with G418, cells were sorted to single cells using a flow cytometer and allowed to expand for two weeks. Clones were screened for insertion of the cassette by PCR as well as FMRP mRNA and protein depletion determined by qPCR, RNA-seq and Western Blot Analysis with a monoclonal FMRP antibody (Proteintech 66548). Lesions at the locus of cutting were identified by PCR using genomic DNA to amplify the locus followed by Topo cloning of the PCR fragment and Sanger sequencing of individual bacterial colonies.

Expression of Fmr1 rescue constructs in CAD cells {#s4-12}
-------------------------------------------------

CAD LoxP FMRP KO cell lines were plated in 12-well plates at 1.0 to 1.5 × 10^5^ cells per well in an DMEM:F12 supplemented with 10% Equafetal 12 to 18 hr before transfection. Cells were then co-transfected with a derivative of pRD-RIPE (containing one of three *Fmr1* rescue cDNAs and Firefly Luciferase fused with one of two 3'UTRs) blended with 1% (wt/wt) of a Cre-encoding plasmid (pCAGGS-Cre). *Fmr1* cDNAs were derived from cDNA clone BC079671.1. To transfect one well of a 12-well plate, 0.5 μg of purified plasmid was mixed with 2 μL Lipofectamine LTX reagent, 1 µL PLUS reagent and 50 μL Opti-MEM following the manufacturer\'s protocol. Cells were incubated with the transfection mixtures overnight, the medium was changed and the incubation continued for another 24 hr before addition of puromycin (5 µg/ml). Incubation with puromycin continued for several days until untransfected control wells were depleted of cells. The cultures with stably integrated constructs were expanded in a full growth medium. Lysates were collected following 2 µg/mL doxycycline induction to assay construct expression via western blot.

Immunoblot of FMRP rescue constructs {#s4-13}
------------------------------------

Expression of rescue constructs in the CAD FMRP KO cell lines were determined by Western blot analysis. Cells with integrated rescue constructs were plated in 6-well plates at 2--3 × 10^5^ cells per well in duplicate. Each cell line was grown in full growth media or full growth media supplemented with 2 µg/mL doxycycline for 48 hr. Lysates were collected with 200 µL RIPA buffer, incubated on ice for 15 min then passed through a 20G needle 20 times. Lysates were stored at −80°C. Denatured lysates were separated by PAGE on 4--12% Bis-Tris gradient gels (Invitrogen) along with Spectra Multicolor Broad Range (Fisher Scientific) using MOPS SDS NuPAGE Running Buffer (Invitrogen) and NuPAGE LDS Sample Buffer (Invitrogen) on ice at 200 V for 1 hr. Gels were transferred to PVDF membranes (Millipore) using NuPAGE Transfer Buffer (Invitrogen) at 15 V for 55 min before being washed three times, 5 min each with PBST at room temperature (RT) with agitation and blocked with 5% Milk Powder (Sigma) in PBST for 1 hr at RT with agitation. Blots were again washed three times, 5 min each in PBST at RT with agitation before being incubated in 1:5000 FMRP mouse monoclonal (Proteintech) primary antibody in 2% Milk Powder in PBST overnight at 4C with agitation or with 1:10,000 Histone H3 mouse monoclonal antibody (Abcam) in 2% milk powder in PBST for 2 hr at room temperature with agitation. Blots were washed three times, 5 min each at RT with agitation and then transferred to Anti-mouse IgG HRP-conjugated secondary antibody in 2% Milk Powder in PBST and incubated at RT for 2 hr. Blots were washed again as previously described and visualized using WesternBright HRP Substrate Kit (Advansta).

smFISH of reporter transcripts {#s4-14}
------------------------------

CAD LoxP FMRP KO cells with Integrated Rescue constructs were plated on PDL coated glass coverslips (neuVitro) within 12-well plates at approximately 2.5 × 10^4^ cells per well in full growth media. Cells were allowed to attach for 2 hr before changing to serum depleted media supplemented with 2 µg/mL doxycycline. Cells were allowed to express constructs and differentiate for 48 hr. Cells were washed once with PBS before being fixed in 3.7% formaldehyde in PBS for 10 min at room temperature then washed twice with PBS before permeabilization with 70% Ethanol at 4°C for 6--8 hr. Cells are incubated in smFISH Wash Buffer at room temperature for 2--5 min. Per hybridization reaction, 2 µL of Stellaris FISH Probes, Firefly Luc with Quasar 670 Dye were added to 200 µL of Hybridization Buffer. An empty opaque tip box is prepared with wet paper towels below with parafilm covering the top. Hybridization buffer with probes (200 µL per reaction) was 'beaded' on top of the parafilm and the PDL coated glass coverslips were placed cell side down onto 'beaded' buffer. The entire tip box is incubated at 37°C over night. Glass coverslips were transferred to fresh 12-well plates cell side up and incubated with smFISH Wash Buffer at 37°C in the dark for 30 min. Buffer was then replaced with fresh smFISH Wash Buffer supplemented with 100 ng/mL DAPI and incubated in the dark at 37°C. DAPI stain was replaced with fresh smFISH Wash Buffer and incubated for 5 min at room temperature. Coverslips were then mounted onto slides with 6 µL Fluoromount G and sealed with nail polish. Slides were imaged on a widefield DeltaVision Microscope with consistent laser intensity and exposure times across samples.

smFISH quantification {#s4-15}
---------------------

Experimental parameters within FISH-quant were set to match widefield DeltaVision microscope and the Stellaris FISH probes ([@bib75]). The excitation and emission wavelengths used were 547 nm and 583 nm respectively which were recorded by a 60X objective with 1.4 numerical aperture with 1.33 refractive index oil. This was captured by a camera such that pixel sizes in the xy were 98.4 nm wide and z pixels a 398 nm wide. Cell outlines were drawn using cell autofluorescence in the FITC channel where somas and neurites were treated as separate cells. Images were first filtered with a 3D 2x gaussian method using the default parameters. Pre-detection was conducted, and spots were fit using FISH-quant default settings and a pixel-intensity threshold set to overestimate detected spots. All thresholding parameters were set tightly around each mean population to exclude gross outliers. Averaged detected spots were inspected for spherical character to ensure quality of detection. These detection settings were the same for every soma and neurite imaged.

Immunofluorescence for HA tagged FMRP rescues in differentiated neurons {#s4-16}
-----------------------------------------------------------------------

CAD FMRP KO cells with doxycycline inducible HA-tagged rescue constructs were plated on top of PDL coated glass coverslips (neuVitro) within 12-well plates at approximately 2.5 × 10^4^ cells per well in in full growth media supplemented with 2.0 µg/mL doxycycline for 2 hr to allow attachment. Media was removed and replaced with differentiation media (lacking serum) supplemented with 2.0 µg/mL doxycycline for an additional 48 hr to induce neurite growth and rescue construct expression. Media was removed and cells were washed with PBS before being fixed with 3.7% formaldehyde at room temperature for 10 min. Cells were washed twice with PBS following fixation for 5 min each. Cells were permeabilized for 30 min at room temperature with 0.3% Triton-X in PBS. Primary HA antibody (GenScript A01244-100) was diluted 1:2000 in PBS containing 1% BSA and 0.3% Triton-X for 1 hr at 37°C. Cells were then rinsed three times with PBS before adding 100 ng/mL DAPI and fluorescent secondary antibody (Cell Signaling Technology 4413S) diluted 1:500 in PBS containing 1% BSA and 0.3% Triton-X for 1 hr at room temperature. Cells were again rinsed three times with PBS then mounted onto slides with Fluoromount G and sealed with nail polish. Slides were imaged on a widefield DeltaVision Microscope with consistent laser intensity and exposure times across samples.

CLIP-qPCR {#s4-17}
---------

One 15 cm plate of cells was used per condition. Expression of the HA-tagged FMRP constructs, Firefly luciferase, and Renilla luciferase were induced with doxycycline for 48 hr prior to the start of the experiment. To crosslink, cells were washed once with cold PBS, then irradiated with 400 mJ / cm^2^ of 254 nm ultraviolet light in a Stratlinker while on ice. Cells were then scraped in 5 mL PBS, centrifuged for 5 min at 2000 g at 4°C, and resuspended in 400 µL lysis buffer (20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl~2~, 0.5% NP-40, 1 mM DTT, 1 mM PMSF). 3 µL of RNase inhibitor were added, and the lysate was incubated on ice for 10 min, then spun at 10,000 g for 15 min at 4°C.

Anti-HA magnetic beads (Pierce) were prepared by washing them three times with buffer A (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween). Lysate was then added to the beads and incubated at 4°C with rotation for 3 hr. Beads were then washed three times with buffer A and incubated with 10U DNase (ThermoFisher) in buffer A supplemented with the 1X buffer that accompanied the enzyme. Beads were then incubated with 20 µg proteinase K (ThermoFisher) in proteinase K buffer (20 mM Tris pH 7.5, 0.1% SDS, 100 mM NaCl) at 55°C for 15 min. The supernatant was then removed from the beads and RNA was isolated using an RNA Clean and Concentrator kit (Zymo).

Firefly luciferase and Renilla luciferase transcript levels were monitored in input and IP samples using Taqman qPCR with probe sets supplied by Life Technologies. Firefly luciferase RNA was quantified using a VIC-labeled probe while Renilla luciferase RNA was quantified using a FAM-labeled probe. The reaction was performed using Taqman Fast Advanced Master Mix (Life Technologies).

Ribosome footprinting of CAD cells {#s4-18}
----------------------------------

CAD cells were grown in the absence of serum for 48 hr to induce neuronal differentiation. Ribosome footprint libraries and companion RNAseq libraries were then produced using the Truseq Ribo Profiling Kit from Illumina according to the manufacturer's instructions. Libraries were sequenced on an Illumina NextSeq sequencer, with about 40 million reads being obtained per sample. Three techincal replicates were performed per condition (WT and knockout; ribosome protected fragments (RPF) and RNAseq) for a total of 12 samples.

Gene level abundance estimates from the RPF and RNAseq data were performed using kallisto and tximport as described above ([@bib6]). Ribosome occupancy values and their changes between wildtype and knockout cells were then calculated using Xtail ([@bib81]).
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###### Xtail outputs for differential localization or ribosome occupancy of transcripts between two different conditions.

\(a\) Xtail output for the differential localization of transcripts in wildtype and FMRP null CAD cells. All log2 fold change values are knockout/wildtype. (b) Xtail output for the differential localization of transcripts in unaffected and FXS motor neurons. All log2 fold change values are FXS/unaffected. (c) Xtail output for the differential localization of transcripts in FMRP null CAD cells rescued with either GFP or full length FMRP. (d) Xtail output for the differential localization of transcripts in FMRP null CAD cells rescued with either FMRP-RGG or full length FMRP. (e) Xtail output for the differential localization of transcripts in FMRP null CAD cells rescued with either FMRP-RGG or GFP. (f) Xtail output for the differential ribosome occupancy of genes in wildtype and FMRP null CAD cells. (g) Xtail output for the differential localization of transcripts in FMRP null CAD cells rescued with either GFP or I304N FMRP. (h) Xtail output for the differential localization of transcripts in FMRP null CAD cells rescued with either I304N or wildtype FMRP.

Data availability {#s7}
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Raw sequencing data and processed files are available through the Gene Expression Omnibus, accession GSE137878.

The following dataset was generated:

GoeringRHudishLIRussHATaliaferroJM2020Regulation of RNA localization by FMR1NCBI Gene Expression OmnibusGSE137878

The following previously published datasets were used:

TaliaferroJMVidakiMOliveiraROlsonSZhanLSaxenaTWangETGraveleyBRGertlerFBSwansonMSBurgeCB2016Profiling of soma and neurite transcriptomesNCBI Gene Expression OmnibusGSE67828

FarrisSWardJMCarstensKESamadiMWangYDudekSM2019Hippocampal Subregions Express Distinct Dendritic Transcriptomes that Reveal Differences in Mitochondrial Function in CA2 \[RNA-seq\]NCBI Gene Expression OmnibusGSE116342

MinisADaharyDManorOLeshkowitzDPilpelYYaronA2013Sub-Cellular Transcriptomics -- Dissection of the mRNA composition in the axonal compartment of sensory neuronsNCBI Gene Expression OmnibusGSE51572
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"FMRP drives RNA localization to neuronal projections through interactions between its RGG box and G-quadruplex sequences\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Gene W Yeo as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by James Manley as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Stephanie Ceman (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript evaluates the role of FMRP on mRNA localization to neurites using genomic approaches to reveal sequence elements and related protein domains that are suggested to be required for binding and/or neurite-targeting. The results mostly confirm current models of RGG-domain function in interacting with G-rich sequences for FMRP, and also confirm known FMRP\'s role in localizing neuritic mRNAs. Nevertheless, if the authors\' argument for separation of function for RNA binding and its requirement for neurite-targeting, versus translation control by FMRP can be strengthened, that would be a novel finding and a requirement for publication.

Essential revisions:

1\) Far stronger evidence that the neurite purification led to expected, enriched mRNAs in the neurites is required. e.g., using neurofilament markers to provide confidence that indeed neurites are being enriched in the purification. Comparing the neurite-enriched mRNAs in the induced neurons to published lists (Zappulo et al., 2017) will strengthen the manuscript.

2\) Ascano et al. identified FLAG tagged FMRP targets in human non-neuronal, proliferative cells (HEK293?), and Darnell et al., 2011, had an additional step to isolate mouse brain polyribosomal mRNAs. This would imply that Ascano\'s FMRP targets are unlikely to be localized mRNAs and Darnell\'s targets are enriched for ribosome-bound mRNAs. Are these datasets really comparable? What is the number of intersecting targets? And are the intersected targets really what should be compared to find FMRP-dependent localized mRNAs? If I understand Figure 2A correctly, 15% of 86 genes (localization reduced) is 12 (seems like a relatively low number to rely on for the downstream non-parametric statistical tests). What would the overlap be if the individual CLIP datasets were used to compute overlaps, and there are other datasets for FMRP CLIPs available now -- what are the overlaps there and how robust are the statistical outcomes downstream?

3\) The reviewers appreciate the use of FXS neurons and do agree that relying on this dataset is preferable than the CAD neurons. Thus, it is important to ensure that the antibodies for FMRP is not cross-reactive to properly interpret the data. If the authors want to utilize the CAD system, it is necessary to evaluate for clarity if the same mRNAs are found localized in both human and mouse systems. Please provide the list of mRNAs identified to the readers.

4\) Further clarity and evidence that the absence of the Nol3 reporter RNA in neurites in the delta RGG FMRP case is due to loss of RNA binding or loss or neurite-targeting. Is the RGG domain required for binding the 3\'UTR/the RNA in the soma and is unable to localize to the neurites, or that it binds but cannot target. Do they also observe an effect on endogenous Nol3 localization? Can CLIP be performed to clarify binding to the Nol3 reporter/endogenous RNA in the presence/absence of the different domains? Truly decoupling localization and translation with luciferase or other assays would be strong.

5\) Can the affinity of the RGG and KH domains for the pools of selected RNA in the RBNS assay be measured? Are there constant regions that flank the variable 40 nts? Could that contain a sequence that binds the KH domains?

10.7554/eLife.52621.sa2

Author response

> Essential revisions:
>
> 1\) Far stronger evidence that the neurite purification led to expected, enriched mRNAs in the neurites is required. e.g., using neurofilament markers to provide confidence that indeed neurites are being enriched in the purification. Comparing the neurite-enriched mRNAs in the induced neurons to published lists (Zappulo et al., 2017) will strengthen the manuscript.

We presented evidence in Figure 1C and Figure 3---figure supplement 2 that the fractionations were clean. If there is leakage of the soma compartment into neurite samples, we would expect to see Histone H3 signal in the neurite samples. We have tried, both in the experiments for this publication and previous ones (Taliaferro et al., 2016), to detect neurofilament markers by Western blotting in our neurite samples but have not had success, likely due to the small amount of material collected from neurites.

As an alternative, we therefore chose to compare transcriptome-wide RNA localization values (projection / soma) in the data presented in this manuscript to those obtained in similar, previously published experiments (Figure 1---figure supplement 6). Overall, we compared projection / soma expression ratios from 65 samples spanning 2 species, 4 laboratories, and 9 cell types. We found that our fractionation data correlated quite well (R \~ 0.6 to 0.8) with almost all of these samples, and that our samples were generally indistinguishable from almost all other previously published ones. Keep in mind that we are correlating ratios of expression values, not just the expression values themselves.

To further analyze this, we found that the similarity of these samples to each was far greater than would be expected by chance (p = 2e-65, Figure 1---figure supplement 7), demonstrating that our data is quite consistent with previously published datasets.

We and many others have found that RNAs encoding ribosomal proteins and electron transport chain proteins are routinely enriched in projections. This was true of all of the samples presented in this manuscript, and the large majority of the 65 samples we analyzed (Figure 1---figure supplements 8 and 9), again demonstrating that our fractionations are consistent with previously published ones.

> 2\) Ascano et al. identified FLAG tagged FMRP targets in human non-neuronal, proliferative cells (HEK293?), and Darnell et al., 2011, had an additional step to isolate mouse brain polyribosomal mRNAs. This would imply that Ascano\'s FMRP targets are unlikely to be localized mRNAs and Darnell\'s targets are enriched for ribosome-bound mRNAs. Are these datasets really comparable? What is the number of intersecting targets? And are the intersected targets really what should be compared to find FMRP-dependent localized mRNAs? If I understand Figure 2A correctly, 15% of 86 genes (localization reduced) is 12 (seems like a relatively low number to rely on for the downstream non-parametric statistical tests). What would the overlap be if the individual CLIP datasets were used to compute overlaps, and there are other datasets for FMRP CLIPs available now -- what are the overlaps there and how robust are the statistical outcomes downstream?

These are important subtleties in these datasets that we are glad the reviewers pointed out. Using data from another publication that performed FMRP CLIP and compiled data from the Ascano and Darnell papers (Maurin et al., 2018) there were 7800 identified targets in the Ascano data and 768 identified targets in the Darnell data. There is an overlap of 597 targets between them, which is a significant overlap (p \< 2e-16, binomial test).

We redid the analysis of overlaps in FMRP binding targets and our identified FMRP localization targets. We used the targets identified in each CLIP-seq dataset (Ascano, Darnell, and Maurin) individually to assess overlap with our list of functional targets. In each case, we observed a significant overlap (binomial test) between the CLIP targets and our localization targets. These plots are included as Figure 2---figure supplements 1, 3, and 5.

Additionally, we reoriented the analysis to ask about the localization sensitivity to FMRP loss for each of the identified sets of FMRP CLIP targets. If our analysis revealed direct targets of FMRP, we would expect that FMRP CLIP targets would be preferentially less localized in response to FMRP loss compared to FMRP CLIP nontargets. This is exactly what we found for each CLIP dataset. CLIP targets were significantly less localized following FMRP loss than expected. These results are presented in Figure 2---figure supplements 2, 4, and 6.

The results of these analyses, both the gene set overlap and localization change of CLIP targets in response to FMRP loss are also included in Figure 2A and B. The set of FMRP CLIP targets for these panels are defined as those shared in common between the Ascano, Darnell, and Maurin datasets.

In short, the results are robust, no matter the CLIP dataset used.

> 3\) The reviewers appreciate the use of FXS neurons and do agree that relying on this dataset is preferable than the CAD neurons. Thus, it is important to ensure that the antibodies for FMRP is not cross-reactive to properly interpret the data. If the authors want to utilize the CAD system, it is necessary to evaluate for clarity if the same mRNAs are found localized in both human and mouse systems. Please provide the list of mRNAs identified to the readers.

We are slightly unclear on what the reviewers mean regarding cross-reactivity. If this is in regard to the Western blot demonstrating that FMRP expression is decreased in FXS samples (Figure 3A), this result is corroborated by the accompanying RNAseq data. In that data, *FMR1* transcript levels are decreased 10-20 fold in the FXS samples relative to unaffected controls (Figure 3B). Transcript levels of the paralogs FXR1 and FXR2 are unaffected. Given that the Western blot shows a clear decrease in protein expression, we believe that the most parsimonious interpretation of this data is that the antibody recognizes FMRP. Further, the FMRP antibody we used shows a clear and complete loss of signal in the CAD knockout line (Figure 1B and Figure 7---figure supplement 9), which would not be the case if there was cross-reactivity.

There is a strong correlation in localization data obtained from CAD cells and localization data obtained from the iPS neurons (R \~ 0.7). This is reflected in Figure 1---figure supplement 6 and has been now mentioned explicitly in the text. Localization data for all genes in the CAD system and the iPS system are presented in Supplementary file 1A and B, respectively.

> 4\) Further clarity and evidence that the absence of the Nol3 reporter RNA in neurites in the delta RGG FMRP case is due to loss of RNA binding or loss or neurite-targeting. Is the RGG domain required for binding the 3\'UTR/the RNA in the soma and is unable to localize to the neurites, or that it binds but cannot target. Do they also observe an effect on endogenous Nol3 localization? Can CLIP be performed to clarify binding to the Nol3 reporter/endogenous RNA in the presence/absence of the different domains? Truly decoupling localization and translation with luciferase or other assays would be strong.

These are important points. To address them, we performed two experiments.

In the first, we assayed the ability of full length FMRP and the RGG truncation to bind the Nol3 reporter in cells, either with or without the G-quadruplex. This was done using a CLIP-qPCR experiment. The Nol3 UTR is attached to the open reading frame of Firefly luciferase. The cells also coexpress *Renilla* luciferase from the same promoter that drives Firefly. By measuring the ratio of Firefly/*Renilla* transcripts using qPCR in Input and crosslink/IP samples, we can therefore measure the relative affinity that different FMRP constructs have for different UTRs.

We found that, in cells, relative to full length FMRP, the RGG truncation mutant was significantly reduced in its ability to interact with G-quadruplex-containing transcripts. Conversely, the ability of the RGG truncation to interact with transcripts that do not have a G-quadruplex was similar to that of the full length protein. These results are presented in Figure 5E and are consistent with our in vitro binding data presented in Figure 4.

To address the ability of the RGG truncation to be trafficked to neurites, we quantified the amount of FMRP protein in the soma and neurite using immunofluorescence. We found that full length FMRP and the RGG truncations displayed similar proportions of FMRP protein in the neurite, suggesting that trafficking of the RGG truncation is not significantly impaired. These results are presented in Figure 5F.

Based on these results, we conclude that it is likely the reduced ability of the RGG truncation to interact with G-quadruplexes that is responsible for the majority of the observed localization defects.

> 5\) Can the affinity of the RGG and KH domains for the pools of selected RNA in the RBNS assay be measured? Are there constant regions that flank the variable 40 nts? Could that contain a sequence that binds the KH domains?

To address this, we performed fluorescence polarization assays to determine affinities. We found that the interaction between the RGG domain and a G-quadruplex RNA had an affinity of approximately 30 nM. This is in line with previous estimates of this affinity (60 nM, Zhang et al., 2014). We observed that lithium acted as a noncompetitive inhibitor in this assay, lowering the amount of RNA that was bound, but not changing the affinity. These data are presented in Figure 4---figure supplement 1.

We attempted to detect binding of the KH domains to RNA, either to the constant regions that flank the variable 40 nt or to the G-quadruplex RNA. We were never able to detect binding of the KH domains to either RNA sequence.
